Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing

被引:5
作者
Hou, Yujuan [1 ]
Urena-Bailen, Guillermo [1 ]
Gol, Tahereh Mohammadian [1 ]
Gratz, Paul Gerhard [1 ]
Gratz, Hans Peter [1 ]
Roig-Merino, Alicia [2 ]
Antony, Justin S. [1 ]
Lamsfus-Calle, Andres [1 ]
Daniel-Moreno, Alberto [1 ]
Handgretinger, Rupert [1 ]
Mezger, Markus [1 ]
机构
[1] Univ Tubingen, Univ Childrens Hosp, Dept Pediat Hematol & Oncol 1, D-72076 Tubingen, Germany
[2] MaxCyte Inc, Rockville, MD 20850 USA
关键词
IL2RG; SCID; CRISPR; Cas9; ssODN; prime editing; somatic mosaicism; IL2RG MUTATION; REVERSION; DIVERSITY; VECTOR; EVENT;
D O I
10.3390/genes13122348
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
X-linked severe combined immunodeficiency (X-SCID) is a primary immunodeficiency that is caused by mutations in the interleukin-2 receptor gamma (IL2RG) gene. Some patients present atypical X-SCID with mild clinical symptoms due to somatic revertant mosaicism. CRISPR/Cas9 and prime editing are two advanced genome editing tools that paved the way for treating immune deficiency diseases. Prime editing overcomes the limitations of the CRISPR/Cas9 system, as it does not need to induce double-strand breaks (DSBs) or exogenous donor DNA templates to modify the genome. Here, we applied CRISPR/Cas9 with single-stranded oligodeoxynucleotides (ssODNs) and prime editing methods to generate an in vitro model of the disease in K-562 cells and healthy donors' T cells for the c. 458T>C point mutation in the IL2RG gene, which also resulted in a useful way to optimize the gene correction approach for subsequent experiments in patients' cells. Both methods proved to be successful and were able to induce the mutation of up to 31% of treated K-562 cells and 26% of treated T cells. We also applied similar strategies to correct the IL2RG c. 458T>C mutation in patient T cells that carry the mutation with revertant somatic mosaicism. However, both methods failed to increase the frequency of the wild-type sequence in the mosaic T cells of patients due to limited in vitro proliferation of mutant cells and the presence of somatic reversion. To the best of our knowledge, this is the first attempt to treat mosaic cells from atypical X-SCID patients employing CRISPR/Cas9 and prime editing. We showed that prime editing can be applied to the formation of specific-point IL2RG mutations without inducing nonspecific on-target modifications. We hypothesize that the feasibility of the nucleotide substitution of the IL2RG gene using gene therapy, especially prime editing, could provide an alternative strategy to treat X-SCID patients without revertant mutations, and further technological improvements need to be developed to correct somatic mosaicism mutations.
引用
收藏
页数:18
相关论文
共 58 条
[1]   Genetic Mosaicism as a Cause of Inborn Errors of Immunity [J].
Aluri, Jahnavi ;
Cooper, Megan A. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (04) :718-728
[2]   A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy [J].
Antony, Justin S. ;
Daniel-Moreno, Alberto ;
Lamsfus-Calle, Andres ;
Raju, Janani ;
Kaftancioglu, Merve ;
Urena-Bailen, Guillermo ;
Rottenberger, Jennifer ;
Hou, Yujuan ;
Santhanakumaran, Vidiyaah ;
Lee, Jun-Hoe ;
Heumos, Lukas ;
Boehringer, Judith ;
Kraegeloh-Mann, Ingeborg ;
Handgretinger, Rupert ;
Mezger, Markus .
CRISPR JOURNAL, 2022, 5 (01) :66-79
[3]   Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors [J].
Justin S. Antony ;
Ngadhnjim Latifi ;
A. K. M. Ashiqul Haque ;
Andrés Lamsfus-Calle ;
Alberto Daniel-Moreno ;
Sebastian Graeter ;
Praveen Baskaran ;
Petra Weinmann ;
Markus Mezger ;
Rupert Handgretinger ;
Michael S. D. Kormann .
Molecular and Cellular Pediatrics, 5 (1)
[4]   Search-and-replace genome editing without double-strand breaks or donor DNA [J].
Anzalone, Andrew V. ;
Randolph, Peyton B. ;
Davis, Jessie R. ;
Sousa, Alexander A. ;
Koblan, Luke W. ;
Levy, Jonathan M. ;
Chen, Peter J. ;
Wilson, Christopher ;
Newby, Gregory A. ;
Raguram, Aditya ;
Liu, David R. .
NATURE, 2019, 576 (7785) :149-+
[5]   Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy [J].
Azhagiri, Manoj Kumar K. ;
Babu, Prathibha ;
Venkatesan, Vigneshwaran ;
Thangavel, Saravanabhavan .
STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
[6]   A genomic view of mosaicism and human disease [J].
Biesecker, Leslie G. ;
Spinner, Nancy B. .
NATURE REVIEWS GENETICS, 2013, 14 (05) :307-320
[7]   Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease [J].
Blanco, Elena ;
Izotova, Natalia ;
Booth, Claire ;
Thrasher, Adrian James .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[8]   Gene therapy for primary immunodeficiency [J].
Booth, Claire ;
Romano, Rosa ;
Roncarolo, Maria Grazia ;
Thrasher, Adrian J. .
HUMAN MOLECULAR GENETICS, 2019, 28 (R1) :R15-R23
[9]   Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor [J].
Bousso, P ;
Wahn, V ;
Douagi, I ;
Horneff, G ;
Pannetier, C ;
Le Deist, F ;
Zepp, F ;
Niehues, T ;
Kourilsky, P ;
Fischer, A ;
de Saint Basile, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (01) :274-278
[10]   Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants [J].
Buckley, RH ;
Schiff, RI ;
Schiff, SE ;
Markert, ML ;
Williams, LW ;
Harville, TO ;
Roberts, JL ;
Puck, JM .
JOURNAL OF PEDIATRICS, 1997, 130 (03) :378-387